Technology for accurate cancer detection and identification

When cancer strikes, many people are prescribed incorrect medication. We're here to fix that.

We're a team of experienced onconlogists and researchers with more than 20 years of experience combined.

We've dedicated our lives to this field, and now we want to share the research we've done to enlighten the medical field.

Latest News

Molecular Theranostics LLC. receives NIH SBIR Phase II support funding for targeted MRI imaging of prostate cancer
July 15, 2017

Han Z, Wu X, Roelle S, Chen C, Schiemann WP, Lu ZR. Targeted gadofullerene for sensitive magnetic resonance imaging and risk-stratification of breast cancer. Nature communications.
2017 Sep 25

Molecular Theranostics LLC. receives NIH SBIR Phase I award for targeted MRI imaging of prostate cancer
June 28, 2015

Want to work with us?